Real-Life Experience of Tralokinumab for the Treatment of Adult Patients with Severe Atopic Dermatitis: A Multicentric Prospective Study-Reference-Cited by-同舟云学术

Real-Life Experience of Tralokinumab for the Treatment of Adult Patients with Severe Atopic Dermatitis: A Multicentric Prospective Study

Published:2023-04 Issue:4 Volume:43 Page:299-306
ISSN:1173-2563
Container-title:Clinical Drug Investigation
language:en
Short-container-title:Clin Drug Investig

Author:

De Greef Axel^ORCID,Ghislain Pierre-Dominique,Bulinckx Audrey,Coster Alison,de Halleux Céline,Damsin Thomas,Jacobs Marie-Claude,Suys Erwin,Zoghaib Samer,Baeck Marie

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s40261-023-01258-7.pdf

Reference20 articles.

1. Leung DY, Guttman-Yassky E. Deciphering the complexities of atopic dermatitis: shifting paradigms in treatment approaches. J Allergy Clin Immunol. 2014;134(4):769–79. https://doi.org/10.1016/j.jaci.2014.08.008.

2. Bylund S, Kobyletzki LB, Svalstedt M, Svensson Å. Prevalence and incidence of atopic dermatitis: a systematic review. Acta Derm Venereol. 2020;100(12):adv00160. https://doi.org/10.2340/00015555-3510.

3. Silverberg JI. Comorbidities and the impact of atopic dermatitis. Ann Allergy Asthma Immunol. 2019;123(2):144–51. https://doi.org/10.1016/j.anai.2019.04.020.

4. Barbarot S, Auziere S, Gadkari A, et al. Epidemiology of atopic dermatitis in adults: results from an international survey. Allergy. 2018;73(6):1284–93. https://doi.org/10.1111/all.1340.

5. Silverberg JI, Barbarot S, Gadkari A, et al. Atopic dermatitis in the pediatric population: a cross-sectional, international epidemiologic study. Ann Allergy Asthma Immunol. 2021;126(4):417-428.e2. https://doi.org/10.1016/j.anai.2020.12.020.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tralokinumab‐induced injection‐site reactions;Contact Dermatitis;2024-08-11

2. Tralokinumab for the Treatment of Adult Atopic Dermatitis in Special Populations;Journal of Asthma and Allergy;2024-08

3. Effectiveness of dupilumab in tralokinumab‐resistant patients with atopic dermatitis: A real‐world experience from two referral centres;Journal of the European Academy of Dermatology and Venereology;2024-06-28

4. Monoclonal antibodies for moderate-to-severe atopic dermatitis: a look at phase III and beyond;Expert Opinion on Biological Therapy;2024-06-02

5. Interleukin antagonists for atopic dermatitis: a new era of therapy;Expert Opinion on Investigational Drugs;2024-06-02